Medifast Inc banner

Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 9.62 USD 0.94% Market Closed
Market Cap: $105.7m

Balance Sheet

Balance Sheet Decomposition
Medifast Inc

Balance Sheet
Medifast Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
1
3
1
2
1
2
2
0
0
14
40
36
25
42
52
75
81
77
164
104
88
94
91
89
Cash Equivalents
1
3
1
2
1
2
2
0
0
14
40
36
25
42
52
75
81
77
164
104
88
94
91
89
Short-Term Investments
0
4
3
3
2
1
1
16
34
20
20
31
28
25
24
24
20
16
11
5
0
56
71
78
Total Receivables
0
1
1
1
1
1
2
4
4
7
3
1
7
3
3
3
1
7
1
1
0
9
0
0
Accounts Receivables
0
1
1
1
0
1
0
1
1
2
2
1
2
2
1
1
1
1
1
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
1
3
3
5
1
0
5
2
1
2
0
5
0
0
0
0
0
0
Inventory
1
3
4
6
8
9
14
11
20
20
21
18
16
13
18
19
39
49
53
180
119
55
42
20
Other Current Assets
1
2
1
4
3
4
3
5
3
3
5
6
7
3
4
4
5
6
6
16
16
11
10
14
Total Current Assets
4
12
10
14
15
17
22
36
61
64
89
92
82
87
101
125
146
154
234
307
223
224
214
202
PP&E Net
5
7
9
10
14
17
22
23
31
39
40
35
34
29
20
19
20
39
38
81
76
67
49
38
PP&E Gross
5
7
9
10
14
17
22
23
31
39
0
35
34
29
20
19
20
39
38
81
76
67
49
38
Accumulated Depreciation
2
2
3
4
5
7
9
13
18
25
0
32
40
47
36
34
35
23
27
33
40
47
58
68
Intangible Assets
1
4
6
5
6
7
6
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
0
0
0
1
1
1
3
2
2
1
6
1
0
0
2
4
2
4
11
18
19
21
8
Other Assets
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
10
N/A
24
+144%
26
+7%
30
+16%
37
+22%
44
+19%
50
+15%
63
+25%
94
+49%
106
+12%
130
+23%
133
+2%
116
-13%
116
+0%
121
+4%
146
+20%
169
+16%
195
+15%
276
+42%
398
+44%
316
-21%
310
-2%
284
-8%
248
-13%
Liabilities
Accounts Payable
0
1
0
2
2
3
4
4
9
13
28
12
12
11
10
16
22
23
36
71
59
48
23
15
Accrued Liabilities
1
1
1
1
1
1
2
4
6
6
0
10
10
8
11
15
29
39
54
74
55
42
39
27
Short-Term Debt
0
0
0
1
1
2
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
1
1
1
1
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
1
1
1
1
0
0
0
0
0
5
5
4
4
6
9
18
21
25
27
2
2
1
Total Current Liabilities
2
3
3
4
5
7
9
9
16
20
29
27
27
24
24
37
60
79
111
170
141
92
64
43
Long-Term Debt
3
5
4
4
4
5
4
5
5
4
4
1
0
0
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
2
1
1
8
7
7
6
4
1
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
10
8
26
20
16
10
6
Total Liabilities
4
N/A
7
+67%
7
-6%
8
+24%
9
+5%
11
+28%
15
+34%
15
N/A
22
+46%
32
+46%
40
+22%
34
-13%
35
+4%
28
-22%
25
-8%
37
+48%
60
+62%
90
+49%
119
+32%
196
+65%
161
-18%
108
-33%
74
-32%
49
-34%
Equity
Common Stock
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
5
3
1
1
6
10
12
23
42
61
77
98
79
89
94
104
131
169
154
190
140
175
177
158
Additional Paid In Capital
10
20
21
22
27
27
25
29
33
36
40
0
1
0
3
5
9
0
8
12
22
27
33
40
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
1
1
1
2
2
2
3
3
24
27
0
0
0
0
0
31
64
5
0
6
0
0
0
Other Equity
0
0
0
0
3
2
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
6
N/A
17
+205%
19
+12%
22
+13%
28
+29%
32
+16%
35
+9%
48
+36%
72
+51%
73
+2%
91
+24%
98
+8%
81
-18%
89
+10%
96
+8%
109
+13%
109
+0%
105
-4%
157
+50%
203
+29%
155
-23%
201
+30%
210
+4%
199
-5%
Total Liabilities & Equity
10
N/A
24
+144%
26
+7%
30
+16%
37
+22%
44
+19%
50
+15%
63
+25%
94
+49%
106
+12%
130
+23%
133
+2%
116
-13%
116
+0%
121
+4%
146
+20%
169
+16%
195
+15%
276
+42%
398
+44%
316
-21%
310
-2%
284
-8%
248
-13%
Shares Outstanding
Common Shares Outstanding
7
10
11
13
14
14
14
15
15
16
14
13
12
12
12
12
12
12
12
12
11
11
11
11
Preferred Shares Outstanding
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett